Greenland Mines Ltd. (GRML)
Nasdaq: GRML · Biological Products, (No Diagnostic Substances) · Omaha, NE · filing with the SEC since 2022
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Report filed | Apr 1, 2026 | Mar 31, 2025 | Apr 17, 2024 | Apr 10, 2023 | · |
| Research and development | 634,187 | 0 | 0 | · | · |
| General and administrative | 3,076,220r | 2,778,991r | 30,546r | 533,992 | · |
| Total operating expenses | 7,146,265 | 5,540,236 | 631,322 | · | · |
| Operating income | -7,146,265 | -5,540,236 | -631,322r | -657,018 | · |
| Interest expense | 2,313,961 | 356,603 | 76,214 | · | · |
| Interest and investment income | · | · | 3,364,038 | 1,656,478r | · |
| Share of profit of equity-method investments | · | · | · | -78,955 | · |
| Other income (expense), net | 115,066 | -251,572 | 78 | · | · |
| Total non-operating income (expense) | -3,405,409 | -610,136 | -76,136 | · | · |
| Income before income taxes | -10,551,674 | -6,150,372 | -707,458r | 1,555,377 | · |
| Income tax expense | · | · | 690,572 | 322,025r | · |
| Net income | -10,551,674 | -6,150,372 | -707,458r | 1,233,352 | · |
| Earnings per share, basic | -0.22 | -0.32 | -0.05 | · | · |
| Earnings per share, diluted | -0.22 | -0.32 | -0.05 | · | · |
| Weighted average shares, basic | 48,489,970 | 19,247,313 | 15,130,393 | · | · |
| Weighted average shares, diluted | 48,489,970 | 19,247,313 | 15,130,393 | · | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestShare of profit of equity-method investments its share of companies it partly owns
us-gaap:IncomeLossFromEquityMethodInvestmentsOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding